Related Experiment Video
Updated: Mar 31, 2026
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Unlocking the Potential of Bioactive Compounds in Pancreatic Cancer Therapy: A Promising Frontier
Silvia Brugiapaglia1, Ferdinando Spagnolo2,3, Claudia Curcio1
1Department of Molecular Biotechnology and Health Sciences, Piazza Nizza 44b, 10126 Turin, Italy.
Abstract:
Pancreatic ductal adenocarcinoma (PDA) is a highly challenging malignancy to treat, with a high mortality rate and limited therapeutic options. Despite advances in cancer research, the prognosis for patients diagnosed with PDA is often poor due to late-stage detection and resistance to conventional therapies. Consequently, there is growing interest in the potential of bioactive compounds as alternative or adjuvant treatments, given their ability to target multiple aspects of cancer biology, offering a more holistic approach to treatment. In the context of PDA, certain bioactive compounds, such as polyphenols (found in fruits, vegetables, and tea), flavonoids, carotenoids and compounds in cruciferous vegetables, have shown potential in inhibiting cancer cell growth, reducing inflammation, and promoting cancer cell apoptosis. This review aims to elucidate the mechanisms, by which these bioactive compounds exert their effects, modulating the oxidative stress, influencing inflammatory pathways and regulating cell survival and death. It also highlights current clinical trials that are paving the way toward incorporating these natural agents into mainstream treatment strategies, with the goal of boosting the efficacy of conventional therapies for PDA.
Insights
Bioactive compounds show promise in treating pancreatic cancer by targeting multiple pathways. This review explores how natural agents like polyphenols can enhance conventional therapies for pancreatic ductal adenocarcinoma.
Area of Science:
- Oncology
- Nutritional Science
- Biochemistry
Background:
- Pancreatic ductal adenocarcinoma (PDA) presents significant treatment challenges due to late detection and therapy resistance.
- Limited therapeutic options and poor prognosis underscore the need for novel treatment strategies.
- Bioactive compounds offer a promising avenue for alternative or adjuvant therapies in PDA management.
Purpose of the Study:
- To review the mechanisms of bioactive compounds in combating PDA.
- To explore the potential of natural agents as adjuncts to conventional PDA treatments.
- To highlight ongoing clinical trials investigating these compounds.
Main Methods:
- Literature review of preclinical and clinical studies on bioactive compounds and PDA.
- Analysis of mechanisms including oxidative stress modulation, anti-inflammatory effects, and apoptosis induction.
- Examination of current clinical trial data for natural agents in PDA treatment.
Main Results:
- Bioactive compounds like polyphenols, flavonoids, and carotenoids demonstrate potential in inhibiting PDA cell growth.
- These compounds modulate key cancer pathways, including oxidative stress and inflammation.
- Evidence suggests these natural agents can promote apoptosis in cancer cells.
Conclusions:
- Bioactive compounds hold significant potential as complementary therapies for pancreatic ductal adenocarcinoma.
- Understanding their mechanisms can guide the integration of natural agents into mainstream PDA treatment.
- Further clinical research is crucial to optimize their use in enhancing conventional therapies.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...